These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11364904)

  • 21. Antivirals update.
    Proj Inf Perspect; 1998 Dec; (26):8-10. PubMed ID: 11366501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amprenavir: a new protease inhibitor nears approval.
    Highleyman L
    BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral agents: the next generation.
    Deeks SG
    AIDS Clin Care; 1998 May; 10(5):33-6, 39-40. PubMed ID: 11365427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trials for protease failure.
    Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access to efavirenz and amprenavir.
    Gilden D
    GMHC Treat Issues; 1998 Oct; 12(10):12. PubMed ID: 11365902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New abacavir data open door to a better treatment paradigm.
    AIDS Alert; 1998 Aug; 13(8):85-7. PubMed ID: 11365647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abacavir sulfate (Ziagen).
    Simmons P
    Res Initiat Treat Action; 1999 Apr; 5(2):8-10. PubMed ID: 11366289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1592 (abacavir, or new name Ziagen) more widely available March 23.
    AIDS Treat News; 1998 Mar; (No 291):6-7. PubMed ID: 11365246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers.
    Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
    AIDS Patient Care STDS; 1998 Apr; 12(4):315-6. PubMed ID: 11361959
    [No Abstract]   [Full Text] [Related]  

  • 33. New treatment options.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1592: small distribution programs begin June, July.
    AIDS Treat News; 1997 May; (No 271):5. PubMed ID: 11364368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging the gap. Bringing new antiretroviral medications into the clinic.
    Williams A
    Adv Nurse Pract; 1999 Jan; 7(1):24-30; quiz 31-2. PubMed ID: 10030167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antiretrovirals and new combinations.
    Havlir DV; Lange JM
    AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When to switch and what to switch to: strategic use of antiretroviral therapy.
    Gulick R
    AIDS Read; 2000 Mar; 10(3):156-61; discussion 171-4. PubMed ID: 10758015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS dementia: 1592 now more available.
    AIDS Treat News; 1997 Nov; (No 282):7. PubMed ID: 11364905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage therapy studies.
    Proj Inf Perspect; 1998 Sep; (25):7. PubMed ID: 11365850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental drug available.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.